Download full report with analyst certification and important disclosures
Feb 28 2023, 07:10 GMT
Uniphar
Robust performance in 2022
- Sectors : Pharma and healthcare
- Companies : Uniphar
DAVY VIEW
Uniphar has reported strong growth in 2022 at both top line and earnings level, driven by organic growth and acquisitions. The gross margin and EBITDA margin expanded despite cost inflation. The company’s geographic presence has significantly broadened, and strong cash conversion has reduced year-end leverage.
